AU2003294446A1 - Regulation of stearoyl-coa desaturase to treat obesity - Google Patents
Regulation of stearoyl-coa desaturase to treat obesityInfo
- Publication number
- AU2003294446A1 AU2003294446A1 AU2003294446A AU2003294446A AU2003294446A1 AU 2003294446 A1 AU2003294446 A1 AU 2003294446A1 AU 2003294446 A AU2003294446 A AU 2003294446A AU 2003294446 A AU2003294446 A AU 2003294446A AU 2003294446 A1 AU2003294446 A1 AU 2003294446A1
- Authority
- AU
- Australia
- Prior art keywords
- stearoyl
- regulation
- treat obesity
- coa desaturase
- desaturase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
- C12Y114/19001—Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42832502P | 2002-11-21 | 2002-11-21 | |
US60/428,325 | 2002-11-21 | ||
PCT/US2003/037354 WO2004047746A2 (en) | 2002-11-21 | 2003-11-21 | Regulation of stearoyl-coa desaturase to treat obesity |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003294446A8 AU2003294446A8 (en) | 2004-06-18 |
AU2003294446A1 true AU2003294446A1 (en) | 2004-06-18 |
Family
ID=32393382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003294446A Abandoned AU2003294446A1 (en) | 2002-11-21 | 2003-11-21 | Regulation of stearoyl-coa desaturase to treat obesity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003294446A1 (en) |
WO (1) | WO2004047746A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043256A1 (en) * | 2001-07-30 | 2005-02-24 | Isis Pharmaceuticals, Inc. | Antisense modulation of stearoyl-CoA desaturase expression |
GT200600046A (en) | 2005-02-09 | 2006-09-25 | COMBINATION THERAPY | |
CA2793423C (en) | 2010-06-11 | 2015-09-15 | Avon Products, Inc. | Use of eclipta prostrata and other ppar-gamma inhibitors in cosmetics and compositions thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5774699A (en) * | 1998-08-14 | 2000-03-06 | Johnson & Johnson Consumer Companies, Inc. | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
WO2002008275A2 (en) * | 2000-07-26 | 2002-01-31 | Bayer Corporation | Genes expressed in obese rat hypothalamus |
-
2003
- 2003-11-21 AU AU2003294446A patent/AU2003294446A1/en not_active Abandoned
- 2003-11-21 WO PCT/US2003/037354 patent/WO2004047746A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003294446A8 (en) | 2004-06-18 |
WO2004047746A2 (en) | 2004-06-10 |
WO2004047746A3 (en) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003239568A1 (en) | Pyrrolotriazinone compounds and their use to treat diseases | |
EP1534074A4 (en) | Combination therapy for the treatment of obesity | |
AU2003278361A1 (en) | Method of water treatment | |
AU2003217159A1 (en) | Compositions and methods for the treatment of wastewater and other waste | |
AU2003271944A1 (en) | Methods for making water treatment compositions and compositions thereof | |
AU2003225088A8 (en) | Regulation of tnf-alpha | |
AU2003295336A1 (en) | Use of etodoclac to treat hyperplasia | |
AU2003214211A1 (en) | Enhancement of iron chelation therapy | |
GB2408558B (en) | Treatment of pipes | |
AU2003302724A1 (en) | Methods of using vectors to treat metabolic disorders | |
AU2002359177A1 (en) | Use of interleukin-6 for treatment of obesity | |
AU2003294446A1 (en) | Regulation of stearoyl-coa desaturase to treat obesity | |
EP1575497A4 (en) | Novel composition and methods for the treatment of psoriasis | |
AU2003268923A1 (en) | Treatment of aml | |
AP2004003174A0 (en) | Treatment of water | |
AU2003241346A1 (en) | Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer | |
AU2003283938A1 (en) | Use of certain compounds in treatment of obesity | |
AU2002951622A0 (en) | Improvements relating to treatment of waste materials | |
AU2003207315A1 (en) | Treatment of muscle damage | |
AU2003263988A1 (en) | Methods and compositions to treat conditions associated with neovascularization | |
AU2003255758A1 (en) | Improvements relating to water treatment | |
IL164218A0 (en) | Use of interleukin-19 to treat ovarian cancer | |
AU2003270615A8 (en) | Treatment of steatosis using hyperthermia | |
AU2003258169A1 (en) | Pharmacological treatment of psoriasis | |
AU2003257965A1 (en) | Phosphonamide and phosphonamide blend compositions and method to treat water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |